>
Biohit´s innovations prevent illnesses and improve quality of life

Innovating for health

Biohit is a Finnish biotechnology company specialising in the development, manufacture and marketing of products and solutions for the early diagnosis and prevention of gastrointestinal and chronic diseases.

We specialize in digestive disease diagnostics, offering a portfolio of unique and patented tests designed to transform clinical practice by making screening, diagnosis and monitoring of gastrointestinal diseases more efficient and cost effective. To learn further on our impact on healthcare and society, please see here.

Our comprehensive diagnostic test range

Our diagnostic prowess extends across a comprehensive range of tests, encompassing both Point-of-Care and laboratory-based solutions. For detailed information about our diagnostic offerings, please see here.

Introducing Acetium®: A breakthrough in gastrointestinal health and smoking cessation

We also have our own unique, patented range of Acetium® products for gastrointestinal health and smoking cessation. Acetium is a Medical Device (EU classification) and is available in pharmacies and supermarkets here.

News

31.01.2025

BIOHIT introduces the FAEX™ Sample System for stool sample collection and handling

Read more
09.10.2024

CEO’s blog Q3/2024 – Hard at work

Read more
01.07.2023

Constitutive Meeting of Biohit Oyj’s Board of Directors

Read more

Events

18.12.2024

We will participate in Medlab Middle East from 3 to 6 February 2025, an event showcasing the future of laboratory technology.

Read more
06.09.2024

Medica , 11.-14. November 2024 Düsseldorf, Germany

Read more
15.07.2024

UEG Week , 12.-15. October 2024 Vienna, Austria

Read more

Product catalogue

Interested?

"*" indicates required fields

Name*
Email*